ARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics. The Company notes the announcement on Friday, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Find the latest Biotech Growth Ord (BIOG.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

The Biotech Growth Trust (BIOG) is managed Geoff Hsu and Josh Golomb at leading global healthcare specialist OrbiMed. The trust provides access to the rapidly evolving biotech sector, seeking ...

Trailing total returns as of 09/04/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

BioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics. The Company notes the announcement on Friday, 19 December 2025 that BioMarin Pharmaceuticals Inc. ("BioMarin") has ...

Get the detailed quarterly/annual income statement for Biotech Growth Ord (BIOG.L). Find out the revenue, expenses and profit or loss over the last fiscal year.

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...